Experimental treatment of chronic lymphocytic leukemia with extracorporeal photochemotherapy
โ Scribed by Knobler, R. M. ;Pirker, R. ;Kokoschka, E. M. ;Ludwig, H. ;Linkesch, W. ;Micksche, M.
- Publisher
- Springer-Verlag
- Year
- 1990
- Weight
- 548 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy developed for cutaneous T-cell lymphoma, has shown promise in treating chronic graft-versus-host disease (cGvHD) in uncontrolled studies. The purpose of this study was to further examine the effects of ECP on cGvHD. E
Since single drug therapy of chronic lymphocytic leukemia (CLL) has not resulted in prolonged remissions of advanced disease, we initiated a program of combination chemotherapy, COP (cycloposphamide, vincristine sulfate, prednisone) for CLL patients with increasing adenopathy, splenomegaly, and/or s
Two patients were treated with photopheresis for marked cardiac allograft rejection with hemodynamic compromise that had become unresponsive to standard therapy. Multiple episodes of rejection had occurred, and initial response to standard therapy was favorable. However, progressive deterioration wa